PHR - Phreesia, Inc.

Phreesia (PHR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Phreesia (PHR) give a sense of how the business performed in the quarter ended April 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates

Phreesia (PHR) delivered earnings and revenue surprises of 12.50% and 3.97%, respectively, for the quarter ended April 2023. Do the numbers hold clues to what lies ahead for the stock?

Tivic Health Systems, Inc. (TIVC) Reports Q1 Loss, Lags Revenue Estimates

Tivic Health Systems, Inc. (TIVC) delivered earnings and revenue surprises of 0% and 27.69%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

• 
  Richardson Electronics (RELL) Outpaces Stock Market Gains: What You Should Know

  Zacks
• 
  EOG Resources (EOG) Gains But Lags Market: What You Should Know

  Zacks

Homology Medicines (FIXX) Reports Q1 Loss, Lags Revenue Estimates

Homology Medicines (FIXX) delivered earnings and revenue surprises of 9.09% and 40.59%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Invitae (NVTA) Reports Q1 Loss, Tops Revenue Estimates

Invitae (NVTA) delivered earnings and revenue surprises of 9.76% and 1.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Why Investors Shouldn't Be Surprised By Phreesia, Inc.'s (NYSE:PHR) P/S

Phreesia, Inc.'s ( NYSE:PHR ) price-to-sales (or "P/S") ratio of 5.6x may look like a poor investment opportunity when...

CareCloud, Inc. (CCLD) Reports Q1 Loss, Lags Revenue Estimates

CareCloud, Inc. (CCLD) delivered earnings and revenue surprises of 9.68% and 3.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Inspire Medical Systems (INSP) Reports Q1 Loss, Tops Revenue Estimates

Inspire (INSP) delivered earnings and revenue surprises of 24.29% and 6.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Investors might be losing patience for Phreesia's (NYSE:PHR) increasing losses, as stock sheds 6.4% over the past week

Phreesia, Inc. ( NYSE:PHR ) shareholders have seen the share price descend 11% over the month. But that doesn't change...

Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates

Phreesia (PHR) delivered earnings and revenue surprises of 7.69% and 2.56%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

Sonendo, Inc. (SONX) Reports Q4 Loss, Tops Revenue Estimates

Sonendo, Inc. (SONX) delivered earnings and revenue surprises of 45.45% and 5.13%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Cooper Companies (COO) to Post Q1 Earnings: What's in Store?

Cooper Companies' (COO) fiscal first-quarter results are likely to reflect segmental strength.

What's in Store for Patterson Companies (PDCO) in Q3 Earnings?

Patterson Companies' (PDCO) fiscal third-quarter results are likely to reflect an improvement at the Animal Health segment.

What Makes Phreesia (PHR) a New Buy Stock

Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Phreesia (PHR) Soars 6.1%: Is Further Upside Left in the Stock?

Phreesia (PHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Phreesia Third Quarter 2023 Earnings: Beats Expectations

Phreesia ( NYSE:PHR ) Third Quarter 2023 Results Key Financial Results Revenue: US$73.1m (up 31% from 3Q 2022). Net...

Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates

Phreesia (PHR) delivered earnings and revenue surprises of 13.64% and 2.73%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?

MEI Pharma, Inc. (MEIP) Reports Q1 Loss, Lags Revenue Estimates

MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 0% and 10.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Neovasc (NVCN) Reports Q3 Loss, Misses Revenue Estimates

Neovasc (NVCN) delivered earnings and revenue surprises of -6.38% and 7.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Cue Health Inc. (HLTH) Reports Q3 Loss, Tops Revenue Estimates

Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 21.82% and 19.92%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Phreesia (NYSE:PHR) investors are sitting on a loss of 62% if they invested a year ago

The nature of investing is that you win some, and you lose some. Anyone who held Phreesia, Inc. ( NYSE:PHR ) over the...

Can Phreesia (PHR) Climb 26% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 25.7% in Phreesia (PHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates

Phreesia (PHR) delivered earnings and revenue surprises of 10.10% and 3.04%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?

Nemaura Medical, Inc. (NMRD) Reports Q1 Loss, Lags Revenue Estimates

Nemaura Medical, Inc. (NMRD) delivered earnings and revenue surprises of -6.25% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Olink Holding AB publ Sponsored ADR (OLK) Reports Q2 Loss, Tops Revenue Estimates

Olink Holding AB publ Sponsored ADR (OLK) delivered earnings and revenue surprises of 69.23% and 3.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?